Business Context and Reporting Period
Company: VisionWave Holdings, Inc. (VWAV)
Filing Type: Form 8-K (Current Report)
Date of Report: June 2, 2026
Event: Entry into a Material Definitive Agreement (Securities Exchange Agreement) with Foresight Autonomous Holdings Ltd. ("Foresight").
Strategic Goal: To establish Foresight as the core operating platform for VisionWave's RF-focused perception systems and related defense, homeland security, and autonomous technology initiatives.
Key Financial Metrics and Transaction Terms
This filing details a stock-for-stock acquisition rather than reporting standard periodic financial results (revenue, profit, cash flow). Key transaction metrics include:
- Total Consideration: $17,500,000 in VisionWave Common Stock to be issued to Foresight.
- Equity Grants: Up to $3,000,000 in management equity grants subject to vesting and performance milestones.
- Acquisition Stake: VisionWave will acquire 52% of Foresight's issued and outstanding share capital (46% at Stage 1, 6% at Stage 2).
- Stage 1 Value: $15,480,769 (88.46% of total consideration), calculated based on the 5-day VWAP of VisionWave stock prior to closing.
- Stage 2 Value: Approximately $2,019,231 (11.54% of total consideration), contingent on a binding pilot project milestone.
- Protected Amounts: $10,062,500 for Stage 1 and $1,312,500 for Stage 2, triggering make-whole share issuances if sale proceeds fall below these thresholds within a two-year protection period.
Material Changes and Transaction Structure
The filing announces a material change in corporate structure through a two-stage acquisition:
- Stage 1 Closing: Expected within 45–60 days of the Effective Date. Foresight issues 46% of its capital to VisionWave in exchange for VisionWave stock valued at $15,480,769.
- Stage 2 Closing: Conditional on the commencement of a binding pilot project utilizing the integrated "Perception Platform" in commercial, defense, or security sectors. Foresight issues an additional 6% of capital for $2,019,231 in VisionWave stock.
- Board Representation: VisionWave gains the right to designate two directors upon Stage 1 Closing and one additional director upon Stage 2 Closing.
- Value Protection Mechanism: A two-year "Protection Period" exists where VisionWave must issue additional shares (or pre-funded warrants) if Foresight sells its VisionWave stock for less than the Protected Amounts. Failure to issue these shares triggers liquidated damages of 1.5% of the shortfall per 30-day period.
Guidance, Risks, and Covenants
Management Commentary and Covenants:
- Use of Proceeds: Foresight covenants to allocate no less than 50% of proceeds from sales of VisionWave Common Stock to the Perception Platform.
- Leak-out Agreement: A 36-month restriction limits Foresight's daily sales of VisionWave stock to 5% of actual daily trading volume.
- Management Retention: A 24-month covenant preserves Foresight's executive team.
- Registration Rights: VisionWave must file Form S-1/S-3 within 45 days of each Closing.
Risks and Forward-Looking Statements:
- Actual results may differ materially from expectations regarding closing timing, milestone achievement, and technology integration.
- The transaction is subject to regulatory approvals, stockholder approvals, and Nasdaq listing requirements.
- Forward-looking statements are subject to risks described in VisionWave's most recent Form 10-K and 10-Q filings.
Investor Verification Checklist
- Verify the exact number of VisionWave shares to be issued based on the 5-day VWAP at the time of Stage 1 Closing.
- Confirm the specific definition and timeline for the "Milestone" (binding pilot project) required for Stage 2 Closing.
- Review the full text of the Securities Exchange Agreement (Exhibit 10.1) for detailed clawback provisions and termination rights.
- Monitor VisionWave's authorized share count to ensure sufficiency for the initial issuance and potential make-whole share obligations.
- Check for any required stockholder or Nasdaq approvals prior to the expected 45–60 day closing window.